Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot

Ohio State University · with DexCom, Inc. · NCT06184373

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–50 · Women only
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
20
US sites recruiting
1
Study start
June 6, 2025
Record last updated
October 16, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

One third of women with gestational diabetes (GDM), diabetes diagnosed during pregnancy, have abnormal glucose levels within 3 years after pregnancy, but follow up is low. Continuous glucose monitors (CGM), a small sensor inserted under the skin, may be able to screen women with GDM for diabetes risk. The investigators will ask postpartum women to use CGM at 6-8 weeks postpartum and answer surveys about quality of life after wearing the CGM. The investigators will collect data on blood glucose trends for future studies if participants find CGM use acceptable. The investigators hope to learn if CGM could improve postpartum follow up experiences for people with recent GDM.

Being studied: Continuous glucose monitor; Oral Glucose Tolerance Test; Hemoglobin A1c

Conditions: Gestational Diabetes; Hyperglycemia

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Women with a viable singleton intrauterine pregnancy
  • Able to understand the study, and having understood, provide written informed consent in English
  • Recent pregnancy affected by gestational diabetes

Exclusion Criteria

  • Pregestational Diabetes (Type I or Type II)
  • Continued use of diabetes medications (including metformin and insulin) immediately after delivery
  • Preterm delivery (\< 37 weeks gestation)
  • Twin or higher order gestation
  • No access to a smartphone
  • Unable or unwilling to wear CGM or return for follow up at postpartum mother-infant dyad clinic
  • Participation in this trial in a prior pregnancy
  • History of skin allergy to adhesive products or CGM

Recruiting US locations

  • Ohio State University Medical Center

    Columbus, OH 43210

    Site contact: Rece Foss · 614-293-8000 · rece.foss@osumc.edu

Study contacts (from the official record)

  • Rachel Gordon, MD, MPH · 614-293-7980 · rachel.gordon@osumc.edu
  • Seuli Brill, MD · 614-293-7980 · seuli.brill@osumc.edu
All diabetes studies in Ohio →
Early Investigation of Glucose Monitoring After Gestational… (NCT06184373) | Bored Studies